Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2012

01.06.2012 | Research Paper

Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization

verfasst von: Russell O. Bainer, Jennifer Taylor Veneris, S. Diane Yamada, Anthony Montag, Mark W. Lingen, Yoav Gilad, Carrie W. Rinker-Schaeffer

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Although metastasis is the most lethal attribute of cancer, critical gaps in our knowledge of how cancer cells effectively colonize distant sites remain. For example, little is known about the cellular and molecular events that occur during the timecourse of metastatic colonization. To address this we are using the mitogen-activated protein kinase kinase 4 (MKK4) metastasis suppressor as a tool to identify these events. Specifically, we report a microarray expression-based strategy to identify genes whose transcription is altered in SKOV3ip.1 human ovarian cancer cells that express ectopic MKK4 throughout the course of in vivo metastatic colonization. The majority of genes identified fell into the categories of cytokinesis, cytoskeleton remodeling, and cell adhesion, and their expression was repressed in MKK4-expressing cells relative to vector controls. The greatest transcriptional divergence was concomitant with impaired proliferation at 14 days post injection (dpi). Specifically, 763 genes were differentially expressed (FDR < 0.05) between lesions that expressed ectopic MKK4 and paired controls. In contrast, only seven genes were differentially expressed at the experimental endpoint, when MKK4-expressing and control cells had formed macroscopic metastases. Application of our cohort of differentially expressed genes to three independent clinical datasets demonstrated a strong correlation between our findings and metastatic phenotypes in patient samples. Our results highlight the dynamic nature of metastatic colonization and reinforce the importance of examining both molecular and cellular phenotypes over time when studying metastasis formation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38(9):2651–2660PubMed Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38(9):2651–2660PubMed
2.
3.
Zurück zum Zitat Taylor JL et al (2008) New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett 272(1):12–22PubMedCrossRef Taylor JL et al (2008) New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett 272(1):12–22PubMedCrossRef
4.
Zurück zum Zitat Thiolloy S et al (2011) Thinking outside the box: using metastasis suppressors as molecular tools. Semin Cancer Biol 21(2):89–98PubMedCrossRef Thiolloy S et al (2011) Thinking outside the box: using metastasis suppressors as molecular tools. Semin Cancer Biol 21(2):89–98PubMedCrossRef
5.
Zurück zum Zitat Cunningham SC et al (2006) MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg 141(11):1095–1099 discussion 1100PubMedCrossRef Cunningham SC et al (2006) MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg 141(11):1095–1099 discussion 1100PubMedCrossRef
6.
Zurück zum Zitat Yamada SD et al (2002) Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 62(22):6717–6723PubMed Yamada SD et al (2002) Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 62(22):6717–6723PubMed
7.
Zurück zum Zitat Yeasmin S et al (2011) MKK4 acts as a potential tumor suppressor in ovarian cancer. Tumour Biol 32(4):661–670PubMedCrossRef Yeasmin S et al (2011) MKK4 acts as a potential tumor suppressor in ovarian cancer. Tumour Biol 32(4):661–670PubMedCrossRef
8.
Zurück zum Zitat Kim HL et al (2001) Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res 61(7):2833–2837PubMed Kim HL et al (2001) Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res 61(7):2833–2837PubMed
9.
Zurück zum Zitat Szmulewitz RZ et al (2011) MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer. doi:10.1002/ijc.26005 Szmulewitz RZ et al (2011) MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer. doi:10.​1002/​ijc.​26005
10.
Zurück zum Zitat Berchuck A et al (2004) Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 190(4):910–925PubMedCrossRef Berchuck A et al (2004) Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 190(4):910–925PubMedCrossRef
11.
Zurück zum Zitat Hickson JA et al (2006) The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 66(4):2264–2270PubMedCrossRef Hickson JA et al (2006) The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 66(4):2264–2270PubMedCrossRef
12.
Zurück zum Zitat Lotan TL et al (2008) c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip. 1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res 68(7):2166–2175PubMedCrossRef Lotan TL et al (2008) c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip. 1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res 68(7):2166–2175PubMedCrossRef
13.
14.
Zurück zum Zitat Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98(1):31–36PubMedCrossRef Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98(1):31–36PubMedCrossRef
15.
Zurück zum Zitat Gautier L et al (2004) affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3):307–315PubMedCrossRef Gautier L et al (2004) affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3):307–315PubMedCrossRef
16.
Zurück zum Zitat Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440–9445PubMedCrossRef Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440–9445PubMedCrossRef
17.
Zurück zum Zitat Dennis G Jr et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3PubMedCrossRef Dennis G Jr et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3PubMedCrossRef
18.
Zurück zum Zitat Huang DW, Sherman B, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57CrossRef Huang DW, Sherman B, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57CrossRef
19.
Zurück zum Zitat Hendrix ND et al (2006) Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66(3):1354–1362PubMedCrossRef Hendrix ND et al (2006) Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66(3):1354–1362PubMedCrossRef
20.
Zurück zum Zitat Riker AI et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13PubMedCrossRef Riker AI et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13PubMedCrossRef
21.
Zurück zum Zitat Pantaleo MA et al (2008) Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer 99(10):1729–1734PubMedCrossRef Pantaleo MA et al (2008) Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer 99(10):1729–1734PubMedCrossRef
22.
Zurück zum Zitat Scotlandi K et al (2009) Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol 27(13):2209–2216PubMedCrossRef Scotlandi K et al (2009) Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol 27(13):2209–2216PubMedCrossRef
23.
Zurück zum Zitat Dressman HK et al (2007) An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol 25(5):517–525PubMedCrossRef Dressman HK et al (2007) An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol 25(5):517–525PubMedCrossRef
24.
Zurück zum Zitat Tothill RW et al (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14(16):5198–5208PubMedCrossRef Tothill RW et al (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14(16):5198–5208PubMedCrossRef
25.
Zurück zum Zitat Shoushtari AN et al (2011) Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol 8(6):333–342PubMed Shoushtari AN et al (2011) Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol 8(6):333–342PubMed
26.
Zurück zum Zitat Lee JY et al (2011) Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. Br J Cancer 104(6):1027–1037PubMedCrossRef Lee JY et al (2011) Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. Br J Cancer 104(6):1027–1037PubMedCrossRef
27.
Zurück zum Zitat Saito N et al (2009) Dynamics of global gene expression changes during brain metastasis formation. Neuropathology 29(4):389–397PubMedCrossRef Saito N et al (2009) Dynamics of global gene expression changes during brain metastasis formation. Neuropathology 29(4):389–397PubMedCrossRef
28.
Zurück zum Zitat Dutertre M et al (2010) Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res 70(3):896–905PubMedCrossRef Dutertre M et al (2010) Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res 70(3):896–905PubMedCrossRef
29.
Zurück zum Zitat van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009PubMedCrossRef van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009PubMedCrossRef
30.
Zurück zum Zitat Ye QH et al (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9(4):416–423PubMedCrossRef Ye QH et al (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9(4):416–423PubMedCrossRef
31.
Zurück zum Zitat Gupta PB et al (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37(10):1047–1054PubMedCrossRef Gupta PB et al (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37(10):1047–1054PubMedCrossRef
32.
Zurück zum Zitat Matsuda Y et al (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11(3):R32PubMedCrossRef Matsuda Y et al (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11(3):R32PubMedCrossRef
33.
Zurück zum Zitat Minn AJ et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518–524PubMedCrossRef Minn AJ et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518–524PubMedCrossRef
34.
Zurück zum Zitat DeLisser H et al (2010) Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proc Natl Acad Sci USA 107(43):18616–18621PubMedCrossRef DeLisser H et al (2010) Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proc Natl Acad Sci USA 107(43):18616–18621PubMedCrossRef
35.
Zurück zum Zitat McGilvray ID et al (2002) Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases. Shock 18(1):51–57PubMedCrossRef McGilvray ID et al (2002) Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases. Shock 18(1):51–57PubMedCrossRef
36.
Zurück zum Zitat Wu SC et al (2008) Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem 283(43):29396–29404PubMedCrossRef Wu SC et al (2008) Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem 283(43):29396–29404PubMedCrossRef
37.
Zurück zum Zitat Marasa BS et al (2009) Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal 2(94):ra69PubMedCrossRef Marasa BS et al (2009) Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal 2(94):ra69PubMedCrossRef
38.
Zurück zum Zitat Yeasmin S et al (2011) Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Int J Cancer 128(1):94–104PubMedCrossRef Yeasmin S et al (2011) Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Int J Cancer 128(1):94–104PubMedCrossRef
Metadaten
Titel
Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization
verfasst von
Russell O. Bainer
Jennifer Taylor Veneris
S. Diane Yamada
Anthony Montag
Mark W. Lingen
Yoav Gilad
Carrie W. Rinker-Schaeffer
Publikationsdatum
01.06.2012
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2012
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-011-9448-y

Weitere Artikel der Ausgabe 5/2012

Clinical & Experimental Metastasis 5/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.